Transplant (Hematologic) Cancer Studies Currently Recruiting Participants at the University of Chicago Comprehensive Cancer Center

Study Number Title
12993B Collection and Use of Mobilized Peripheral Blood Stem Cells from Patients with Hematologic Malignancies
15147A Collection of Research Blood and/or Marrow Samples in Donors Undergoing Bone Marrow, Stem Cell or Lymphocyte Collection.
15953A Protocol for a research database for hematopoietic Stem Cell Transplanation and Marrow Toxic Injuries _ REPLACES 13239B
15961A Protocol for a Research Sample Repository For Allogeneic Hematopioetic Stem Cell Transplanation_ REPLACES 12590A
09-221-B Emergency use of PROCHYMAL (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) for the Treatment of Patients Exposed to an Acute Radiation Dose Sufficient to Elicit the Gastrointestinal Sub-syndrome of the Acute Radiation Syndrome
Select
09-355-A A Multicenter Study of Hematopoietic Stem Cell Donor Safety and Quality of Life
09-361-A A Retrospective Review of Cylopphosphamide and G-CSF Autologous Perpherial Blood Hematopoietic Stem Mobilization (PBSC) in Patiens within Multiple Myeloma Ontcomes Based on Specific Patient Factors
10-064-B Molecular characterization of hematopoietic malignancies
Select
10-551-B Pilot study T cell depletion in the setting of autologous stem cell transplantation for patients with multiple myeloma
11-0118 KIR Genotyping for Unrelated Donor (URD) Selection Prior to Hematopoietic Cell Transplantation (HCT) for AML: Selecting a Favorable KIR Donor
Select
11-0322 A Randomized, Prospective, Double Blind, Placebo Controlled, Phase 3 Study of US-ATG-F Prophylaxis as a Supplement to Standard of Care Prophylaxis to Prevent Moderate to Severe Chronic GVHD in Adult Acute Myeloid Leukemia, Acute Lymphoid Leukemia, and Myelodysplastic
Select
11-0270 Pharmacokinetics, Safety and Tolerability of Intravenous Posaconazole Solution followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1B) (P05520)
Select
12-1191 Pilot study of Prophylactic Dose-Escalation Donor Lymphocyte Infusion After T Cell Depleted Allogeneic Stem Cell Transplant in High Risk Patients With Hematologic Malignancies
Select
12-1924 A Prospective Study of Optimal Cord Selection for Haplo-Cord Transplantation: Targeting the Inherited Paternal Antigen (IPA) and Matching for the Non-Inherited Maternal Antigen (NIMA)
Select
12-2161 A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients with Hematological Malignancies
12-1856 The University of Chicago Transplant Immunology and Immunogenetics Laboratory Research Registry and Specimen Collection Protocol for Biomedical Research

To learn more about cancer clinical trials or to make an appointment, call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials). Although our objective is to provide an updated listing of clinical trials, please note that a listing here does not guarantee that a trial is open or available to any specific patient. Additional trials may be available that are not listed. Complete information is available only from a treating physician.